40 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
as well as critical accounting policies and practices used by us;
coordinating the oversight and reviewing the adequacy of our internal control over … Oversight
The board of directors of the Company has an independent chair, Mr. Iwicki, who has authority, among other things, to call and preside
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.
(w) Title to Real and Personal Property. The Company
8-K
EX-1.1
mdy6i1obh
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
8-K
EX-1.1
s15rl3r
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
a5ojl29om7q2i
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am